Your browser doesn't support javascript.
loading
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer.
Katayama, Ayaka; Miligy, Islam M; Shiino, Sho; Toss, Michael S; Eldib, Karim; Kurozumi, Sasagu; Quinn, Cecily M; Badr, Nahla; Murray, Ciara; Provenzano, Elena; Callagy, Grace; Martyn, Cian; Millican-Slater, Rebecca; Purdie, Colin; Purnell, Dave; Pinder, Sarah E; Oyama, Tetsunari; Shaaban, Abeer M; Ellis, Ian; Lee, Andrew H S; Rakha, Emad A.
  • Katayama A; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, UK.
  • Miligy IM; Diagnostic Pathology, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Shiino S; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, UK.
  • Toss MS; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Eldib K; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, UK.
  • Kurozumi S; Department of Breast Surgery, National Cancer Centre Hospital, Tokyo, Japan.
  • Quinn CM; Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, Nottingham City Hospital, University of Nottingham, Nottingham, UK.
  • Badr N; Department of Histopathology, Nottingham University Hospitals, Nottingham, UK.
  • Murray C; Department of Breast Surgery, International University of Health and Welfare, Narita, Japan.
  • Provenzano E; Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Callagy G; Department of Histopathology, St. Vincent's University Hospital, Dublin, and School of Medicine, University College Dublin, Dublin, Ireland.
  • Martyn C; Department of Pathology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
  • Millican-Slater R; Institute of Cancer and Genomic Sciences, The University of Birmingham, Edgebaston, Birmingham, UK.
  • Purdie C; Department of Histopathology, St. Vincent's University Hospital, Dublin, and School of Medicine, University College Dublin, Dublin, Ireland.
  • Purnell D; Department of Histopathology, Cambridge University NHS Foundation Trust, Cambridge, UK.
  • Pinder SE; Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland.
  • Oyama T; Discipline of Pathology, School of Medicine, Lambe Institute for Translational Research, NUI Galway, Galway, Ireland.
  • Shaaban AM; Department of Histopathology, St James's University Hospital, Leeds, UK.
  • Ellis I; Department of Breast Pathology, Ninewells Hospital and Medical School, Dundee, UK.
  • Lee AHS; Histopathology department, University Hospitals of Leicester, Leicester, UK.
  • Rakha EA; Division of Cancer Studies, King's College London, Guy's Hospital, London, UK.
Mod Pathol ; 34(7): 1271-1281, 2021 07.
Article en En | MEDLINE | ID: mdl-33526875
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Guideline / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article